Sales & Marketing Bad KOL data is expensive: Harnessing high-quality data for ... As biopharmas increasingly rely on AI and advanced data-driven technologies, evaluating the quality of data is critical.
R&D Defining, building, and implementing the next wave of biopha... In a new podcast, pharmaphorum speaks with two PharmaLex experts about navigating complex R&D processes to unleash the next wave of biopharma.
R&D The longitudinal history of medicines innovation: Part One As we move forwards in public discussions on pharmaceutical innovation and its value to patients and society, it is helpful to ground conversations in a solid understanding of how medicines
Partner Content Partner Content Dr. Eric Blomme, AbbVie, Chair Invite & Interview Snippet fo... Dr. Eric Blomme, AbbVie, Chair Invite & Interview Snipp
News Isomorphic adds MSD to partner roster, and other deals It's been a busy dealmaking week, with Isomorphic Labs, fresh from a $5 billion financing, adding MSD to its list of research alliances.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.